Mantle Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Mantle Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
This clinical trial update reports a completed retrospective study of temsirolimus in renal cell carcinoma and mantle cell lymphoma. Results…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating vorinostat plus FND in relapsed or refractory mantle cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 study evaluating SAR245409 in combination with rituximab or bendamustine plus rituximab in patients with indolent non-Hodgkin lymp…
-
FDA approval · 2016-03-21FDA Approved: IMBRUVICA — Supplemental Application (Pharmacyclics LLC)
FDA approved a supplemental application for IMBRUVICA (ibrutinib) filed by Pharmacyclics LLC. The document indicates FDA action on a supplem…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Study of Mantle Cell Lymphoma Treatment by RiBVD [Phase 2]
A Phase 2 clinical trial evaluating the RiBVD regimen for mantle cell lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating a combination of Rituximab, Bortezomib, Bendamustine, and Dexamethasone in patients with Mantle cell lym…
-
EMA safety_alert · 2016-03-11EMA reviews cancer medicine Zydelig
The EMA reviews the cancer medicine Zydelig (idelalisib) for potential safety concerns and evaluates available data.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL) [Phase 2]
Phase 2 pilot trial of oral vorinostat plus eltrombopag in lymphoma was terminated.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma [Phase 2]
Phase 2 study evaluating the R-MACLO-IVAM regimen with thalidomide in untreated mantle cell lymphoma; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating everolimus in relapsed or refractory mantle cell lymphoma has completed.
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) [Phase 2]
A Phase 2 study of SCH 727965 in mantle cell lymphoma or B-cell chronic lymphocytic leukemia has been terminated.
-
FDA approval · 2015-07-08FDA Approved: TREANDA — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for TREANDA (bendamustine hydrochloride) submitted by Cephalon, LLC.
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 study sponsored by the National Cancer Institute evaluating dasatinib in patients with metastatic or unresectable solid tumors and l…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 in combination with azacitidine (Vidaza) for relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma [Phase 2]
A Phase 2 trial evaluating infusion of blood cells (lymphocytes) to stimulate the immune system for fighting leukemia/lymphoma was terminate…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. [Phase 1]
Phase 1 trial of palbociclib (PD-0332991) in patients with mantle cell lymphoma has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma [Phase 2]
Phase 2 trial of Zevalin (ibritumomab tiuxetan) and Velcade (bortezomib) for relapsed/refractory mantle cell lymphoma was terminated; result…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update reporting completion of a study evaluating interleukin-12 in patients with various previously treated non-Hodgkin lymph…